$7.14
-17.26%$7.14
-17.26%Stem nu om het sociale sentiment van Injective te zien
*De verwachte winst wordt berekend op basis van de gemiddelde tokenprijs van dit jaar. Let op: dit is geen financieel advies.

Door de volatiliteit van de cryptomarkt is iedereen benieuwd naar de richting en prijs van Injective, zowel op de korte als lange termijn.
Injective kan vanaf nu tot 2030 stijgen tot $8.63.
Het potentiële rendement (ROI) van het kopen van Injective tegen de huidige prijs van $7.14 is +20.00% , De all-time-high van Injective is $52.62 .
Injective is de afgelopen 24 uur -17.26% en in de afgelopen 7 dagen -5.14%. Voor meer info, check nu Injective prijs.
Huidige prijs
$7.14Marktkapitalisatie (USD)
714.30MCirculerend aanbod
100.00M INJMaximale voorraad
∞For 2026, Injective is estimated to achieve an average price of $5.36, with an expected of high $5.84 and a potential low of $4.23. Buying Injective at the current price of $7.14 can potentially yield -24.00% in 2026.
Past trends and patterns indicate that Injective may make a high of $6.04, with the lowest price of $5.26 in 2027. So buying Injective at the current price of $7.14, the potential ROI based on average price of $5.6 in 2027 will be -21.00%.
Injective is forecasted to hover around $5.82 for most parts in 2028, with an expected low of $4.66 and expected high of $8.03. Based on this forecast, you can expect a potential ROI of $7.14 if you buy at current market price of -18.00%.
Based on historical data, Injective may make a high of $10.32, with $6.65 as the lowest price in 2029. So if you were to buy Injective at the current price of $7.14, the potential ROI for you in 2029 is $6.93 as it makes its way to the average price of -2.00%.
In 2030, the lowest price to be seen from Injective is estimated at $8.02, while the peak price of the year may well be around $10.18. With an average price of $8.63, your potential ROI in 2030 if you buy at market price of $7.14 is +20.00%.
Following the market sentiment in previous years, Injective is predicted to make movements between $7.05 and $9.68, with the average price of $9.4 in 2031. Buying Injective at current price of $7.14 should bring you the potential ROI of +31.00% if you HODL it until 2031.
| Jaar | Minimale prijs | Hoogste prijs | Gemiddelde prijs | Wijzigen |
|---|---|---|---|---|
| 2026 | $4.23 | $5.84 | $5.36 | -24.00% |
| 2027 | $5.26 | $6.04 | $5.6 | -21.00% |
| 2028 | $4.66 | $8.03 | $5.82 | -18.00% |
| 2029 | $6.65 | $10.32 | $6.93 | -2.00% |
| 2030 | $8.02 | $10.18 | $8.63 | +20.00% |
| 2031 | $7.05 | $9.68 | $9.4 | +31.00% |
Injective | 0.1837 INJ |
|---|---|
$0.9993USD | |
€0.8597EUR | |
₹95.83INR | |
Rp18,034.81IDR | |
$1.39CAD | |
£0.7439GBP | |
฿32.64THB |
Injective | 0.1837 INJ |
|---|---|
₽73.72RUB | |
R$5.06BRL | |
د.إ3.67AED | |
₺46.02TRY | |
¥6.78CNY | |
¥159.93JPY | |
$7.83HKD |

INJ announces a 50,000 token buyback plan, integrating stablecoin payments, RWA assets, and AI features following its mainnet upgrade. Analyzing the strategic logic behind this three-in-one narrative and the competitive landscape among public blockchains.

BlackRock ranks first in the cash flow of Bitcoin spot ETFs, and MicroStrategy is buying more Bitcoin. JPMorgan Chase believes that the probability of approval for the May spot Ethereum ETF does not exceed 50%.
Injective(INJ) heeft een toekomstige prijsvoorspelling van $9.4. Naar verwachting kan Injective(INJ) rond 2027 een nieuw hoogtepunt van $52.62 bereiken. Gezien de marktkapitalisatie ranking van 76, zal Injective(INJ) waarschijnlijk zijn sterke groeimomentum voortzetten.